Celyad Oncology SA American Depositary Shares
CYAD
CYAD was delisted on the 18th of May, 2023.
6 hedge funds and large institutions have $5.46M invested in Celyad Oncology SA American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
14% less funds holding
Funds holding: 7 → 6 (-1)
16% less capital invested
Capital invested by funds: $6.47M → $5.46M (-$1.01M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$10.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$322K |
| 2 |
Morgan Stanley
New York
|
-$51.1K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$15.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| $5.23M | -$322K | -40,890 | -5% |
|
|
2
Morgan Stanley
New York
| $166K | -$51.1K | -6,496 | -22% |
|
|
3
Wells Fargo
San Francisco,
California
| $45K | -$15.3K | -1,943 | -23% |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | +$10.9K | +1,392 | +278% |
|
5
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
CYAD Hedge Fund Activity: Q1 2021 in Review
6 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q1 2021, worth a combined $5.46M — down 16% from $6.47M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CYAD and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $10.9K. The largest seller was Victory Capital Management, cutting an estimated $322K.
- 6 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q1 2021, down from 7 in Q4 2020.
- Funds reported $5.46M of Celyad Oncology SA American Depositary Shares stock for Q1 2021, down 16% quarter-over-quarter.
- 0 funds opened new Celyad Oncology SA American Depositary Shares positions in Q1 2021 and 1 closed out, a net change of -1 holder.
- The largest Celyad Oncology SA American Depositary Shares buyer in Q1 2021 was UBS Group, an estimated $10.9K added.
- The largest Celyad Oncology SA American Depositary Shares seller in Q1 2021 was Victory Capital Management, an estimated $322K sold.
Based on aggregated 13F filings for Q1 2021.